WallStreetZenWallStreetZen

NASDAQ: ELEV
Elevation Oncology Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Elevation Oncology earnings were -$39.7M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest ELEV earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$10.5M, down 2.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ELEV reported annual earnings of -$45.7M, with -51.9% growth.

ELEV earnings history

Current Revenue
$0.0
Current Earnings
-$39.7M
Current Profit Margin
0%

ELEV Return on Equity

Current Company
-58%
Current Industry
22.8%
Current Market
33.7%
ELEV's Return on Equity (-58%)... subscribe to Premium to read more.
High Return on Equity Performance

ELEV Return on Assets

Current Company
-38.5%
Current Industry
3.5%
ELEV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ELEV announces earnings.

ELEV Return on Capital Employed

Current Company
-35.11%
Current Industry
21.3%
ELEV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELEV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ELEV-$39.23M-$39.70MN/A-$0.79
ENLV-$21.76M-$22.29MN/A-$1.18
DYAI-$7.57M-$7.74MN/A-$0.28
OCEA-$97.33M-$98.59MN/A-$3.91
ACST-$14.51M-$11.45MN/A-$1.14
View Top Biotech Stocks

Elevation Oncology Earnings Reports & History FAQ

What were Elevation Oncology's earnings last quarter?

Elevation Oncology (NASDAQ: ELEV) reported Q2 2024 earnings per share (EPS) of -$0.18, up 50% year over year. Total ELEV earnings for the quarter were -$10.46 million. In the same quarter last year, Elevation Oncology's earnings per share (EPS) was -$0.36.

If you're new to stock investing, here's how to buy Elevation Oncology stock.

Is Elevation Oncology profitable or losing money?

As of the last Elevation Oncology earnings report, Elevation Oncology is currently losing money. Elevation Oncology's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$39.70 million, a 53.32% decrease year over year.

What was ELEV's earnings growth in the past year?

As of Elevation Oncology's earnings date in Q4 2024, Elevation Oncology's earnings has grown year over year. ELEV earnings in the past year totalled -$39.70 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.